drugset / Trial / NCT00473525
12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this Phase 2a study is to evaluate the efficacy, safety and tolerability, of multiple parallel doses of PF-00734200 following oral administration to adult human subjects with T2DM who currently are on a stable dose of metformin.
Timeline
- Start
- 2007-07
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gosogliptin | Small molecule | 2 mg | Oral |
| Subject | Gosogliptin | Small molecule | 5 mg | Oral |
| Subject | Gosogliptin | Small molecule | 10 mg | Oral |
| Subject | Gosogliptin | Small molecule | 20 mg | Oral |